Format

Send to

Choose Destination
Int J Nanomedicine. 2019 Jul 29;14:5925-5942. doi: 10.2147/IJN.S217923. eCollection 2019.

Mesenchymal stem cell therapy assisted by nanotechnology: a possible combinational treatment for brain tumor and central nerve regeneration.

Kwon S#1, Yoo KH#2, Sym SJ2, Khang D1,3,4.

Author information

1
Lee Gil Ya Cancer and Diabetes Institute, Gachon University, Incheon 21999, South Korea.
2
Department of Internal Medicine, Division of Hematology, School of Medicine, Gachon University Gil Medical Center, Incheon, 21565, South Korea.
3
Department of Gachon Advanced Institute for Health Science & Technology (Gaihst), Gachon University, Incheon 21999, South Korea.
4
Department of Physiology, School of Medicine, Gachon University, Incheon 21999, South Korea.
#
Contributed equally

Abstract

Mesenchymal stem cells (MSCs) intrinsically possess unique features that not only help in their migration towards the tumor-rich environment but they also secrete versatile types of secretomes to induce nerve regeneration and analgesic effects at inflammatory sites. As a matter of course, engineering MSCs to enhance their intrinsic abilities is growing in interest in the oncology and regenerative field. However, the concern of possible tumorigenesis of genetically modified MSCs prompted the development of non-viral transfected MSCs armed with nanotechnology for more effective cancer and regenerative treatment. Despite the fact that a large number of successful studies have expanded our current knowledge in tumor-specific targeting, targeting damaged brain site remains enigmatic due to the presence of a blood-brain barrier (BBB). A BBB is a barrier that separates blood from brain, but MSCs with intrinsic features of transmigration across the BBB can efficiently deliver desired drugs to target sites. Importantly, MSCs, when mediated by nanoparticles, can further enhance tumor tropism and can regenerate the damaged neurons in the central nervous system through the promotion of axon growth. This review highlights the homing and nerve regenerative abilities of MSCs in order to provide a better understanding of potential cell therapeutic applications of non-genetically engineered MSCs with the aid of nanotechnology.

KEYWORDS:

anti-inflammation; glioblastoma multiforme; mesenchymal stem cell; nanocarrier; nerve regeneration; tumor inhibition

PMID:
31534331
PMCID:
PMC6681156
DOI:
10.2147/IJN.S217923
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Dove Medical Press Icon for PubMed Central
Loading ...
Support Center